Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$24.82
-0.17 (-0.68%)
(As of 10/8/2024 ET)

About Avantor Stock (NYSE:AVTR)

Key Stats

Today's Range
$24.70
$25.05
50-Day Range
$24.30
$27.70
52-Week Range
$16.63
$28.00
Volume
4.19 million shs
Average Volume
6.46 million shs
Market Capitalization
$16.86 billion
P/E Ratio
63.64
Dividend Yield
N/A
Price Target
$28.00
Consensus Rating
Moderate Buy

Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
95th Percentile Overall Score

AVTR MarketRank™: 

Avantor scored higher than 95% of companies evaluated by MarketBeat, and ranked 66th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avantor has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 12 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avantor has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Avantor's stock forecast and price target.
  • Earnings Growth

    Earnings for Avantor are expected to grow by 21.78% in the coming year, from $1.01 to $1.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avantor is 63.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.56.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avantor is 63.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 126.56.

  • Price to Earnings Growth Ratio

    Avantor has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Avantor has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avantor's valuation and earnings.
  • Percentage of Shares Shorted

    5.18% of the outstanding shares of Avantor have been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 4.03%, indicating that investor sentiment is improving.
  • Dividend Yield

    Avantor does not currently pay a dividend.

  • Dividend Growth

    Avantor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.18% of the outstanding shares of Avantor have been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 4.03%, indicating that investor sentiment is improving.
  • News Sentiment

    Avantor has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Avantor this week, compared to 7 articles on an average week.
  • Search Interest

    1 people have searched for AVTR on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 2 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avantor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $88,336.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of Avantor is held by insiders.

  • Percentage Held by Institutions

    95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avantor's insider trading history.
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock News Headlines

[SHOCKING] Crypto Document Leak…
The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.
What 11 Analyst Ratings Have To Say About Avantor
See More Headlines

AVTR Stock Analysis - Frequently Asked Questions

Avantor's stock was trading at $22.83 at the beginning of the year. Since then, AVTR stock has increased by 8.7% and is now trading at $24.82.
View the best growth stocks for 2024 here
.

Avantor, Inc. (NYSE:AVTR) posted its quarterly earnings data on Friday, July, 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. The company had revenue of $1.70 billion for the quarter, compared to analysts' expectations of $1.70 billion. Avantor had a trailing twelve-month return on equity of 12.40% and a net margin of 5.28%.

Avantor (AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Top institutional investors of Avantor include Artemis Investment Management LLP (0.59%), Country Trust Bank (0.27%), Handelsbanken Fonder AB (0.05%) and SG Americas Securities LLC (0.01%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Christophe Couturier, Thomas A Szlosek, Steven W Eck and Rajiv Gupta.
View institutional ownership trends
.

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA) and CVS Health (CVS).

Company Calendar

Last Earnings
7/26/2024
Today
10/08/2024
Next Earnings (Confirmed)
10/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.00
High Stock Price Target
$34.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+12.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
15 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
6.61%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$1.57 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
669,077,000
Market Cap
$16.85 billion
Optionable
Optionable
Beta
1.33
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NYSE:AVTR) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners